STOCK TITAN
  1. Home
  2. Financials
  3. ADPT
  4. Revenue

Adaptive Biotechnologies Corporation (ADPT) Revenue by Year

ADPT

Adaptive Biotechnologies Corporation generated $277.0M in revenue in fiscal year 2025. This represents an increase of 54.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $308.1M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Adaptive Biotechnologies Corporation has filed alongside them.

FY2025 annual
Revenue $277.0M
YoY +54.8%
5Y CAGR +23.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADPT Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Revenue$308.1M$277.0M+54.8%$179.0M+5.1%$170.3M-8.1%$185.3M+20.1%$154.3M+56.9%$98.4M+15.6%$85.1M+52.8%$55.7M+44.8%$38.4M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ADPT Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$71.6M+21.5%$70.9M+35.1%$71.7M+51.0%$94.0M+102.4%$58.9M+36.3%$52.4M+25.2%$47.5M+3.7%$46.4M+22.5%$43.2M-11.7%$41.9M+11.2%$45.8M-17.1%$37.9M-20.7%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Adaptive Biotechnologies Corporation financials

Frequently Asked Questions

What was Adaptive Biotechnologies Corporation's revenue in fiscal year 2025?

Adaptive Biotechnologies Corporation generated $277.0M in revenue in fiscal year 2025.

How fast is Adaptive Biotechnologies Corporation's revenue growing?

Adaptive Biotechnologies Corporation (ADPT) revenue rose by 54.8% year over year, from $179.0M to $277.0M in fiscal year 2025.

What is Adaptive Biotechnologies Corporation's revenue over the last twelve months?

Adaptive Biotechnologies Corporation (ADPT) reported $308.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 9 fiscal years this page covers, Adaptive Biotechnologies Corporation (ADPT) revenue went from $38.4M in fiscal year 2017 to $277.0M in fiscal year 2025.

Adaptive Biotechnologies Corporation (ADPT) reported $71.6M in revenue in Q2 2026. This represents an increase of 21.5% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Adaptive Biotechnologies Corporation (ADPT) reported on that line in every period on record.